Platinum Investment Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Platinum Investment Management’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,248	Closed	-$163K	–	157
2023 Q3	$163K	Sell	14,248 -15,121	-51%	-$281K	0.01%	105
2023 Q2	$731K	Hold	29,369	–	–	0.03%	101
2023 Q1	$1.07M	Hold	29,369	–	–	0.04%	100
2022 Q4	$1.77M	Hold	29,369	–	–	0.07%	82
2022 Q3	$2.2M	Buy	29,369 +15,058	+105%	+$1.57M	0.09%	73
2022 Q2	$1.64M	Buy	14,311 +5,530	+63%	+$649K	0.06%	89
2022 Q1	$1.66M	Hold	8,781	–	–	0.05%	89
2021 Q4	$3.04M	Buy	8,781 +5,207	+146%	+$2.02M	0.08%	81
2021 Q3	$1.2M	Buy	3,574 +3,541	+10,730%	+$1.82M	0.03%	115
2021 Q2	$27K	Buy	+33	New	+$25.6K	﹤0.01%	144

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Platinum Investment Management's OMIC Position: Q4 2023 in Review

Platinum Investment Management sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q4 2023, closing a stake of 14,248 shares — an estimated $163K sold.

Platinum Investment Management first reported a position in OMIC in Q2 2021 and held it in 10 quarters. The position peaked at $3.04M in Q4 2021. 47 funds tracked by Wall St. Rank hold OMIC as of Q4 2023.

Platinum Investment Management reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Platinum Investment Management sold 14,248 Singular Genomics Systems, Inc. Common Stock shares in Q4 2023, an estimated $163K.
Platinum Investment Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Platinum Investment Management's Singular Genomics Systems, Inc. Common Stock position peaked at $3.04M in Q4 2021.
47 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2023.

Based on Platinum Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.